VMAT2 Safeguards β-Cells Against Dopamine Cytotoxicity Under High-Fat Diet-Induced Stress.
Daisuke SakanoFumiya UefuneHiraku TokumaYuki SonodaKumi MatsuuraNaoki TakedaNaomi NakagataKazuhiko KumeNobuaki ShirakiShoen KumePublished in: Diabetes (2020)
Vesicular monoamine transporter 2 (VMAT2) uptakes cytoplasmic monoamines into vesicles for storage. VMAT2 plays a role in modulating insulin release by regulating dopamine levels in the pancreas, although the exact mechanism remains elusive. We found that VMAT2 expression in β-cells specifically increases under high blood glucose conditions. The islets isolated from β-cell-specific Vmat2 knockout (βVmat2KO) mice show elevated insulin secretion levels in response to glucose stimulation. Under prolonged high-fat diet feedings, the βVmat2KO mice exhibit impaired glucose and insulin tolerance and progressive β-cell dysfunction. Here we demonstrate VMAT2 uptake of dopamine to protect dopamine from degradation by monoamine oxidase, thereby safeguarding β-cells from excess reactive oxygen species (ROS) exposure. In the context of high demand for insulin secretion, the absence of VMAT2 leads to elevated ROS in β-cells, which accelerates β-cell dedifferentiation and β-cell loss. Therefore, VMAT2 controls the amount of dopamine in β-cells, thereby protecting pancreatic β-cells from excessive oxidative stress.
Keyphrases
- induced apoptosis
- blood glucose
- oxidative stress
- cell cycle arrest
- high fat diet induced
- high fat diet
- reactive oxygen species
- single cell
- cell therapy
- insulin resistance
- type diabetes
- cell death
- uric acid
- endoplasmic reticulum stress
- glycemic control
- poor prognosis
- stem cells
- skeletal muscle
- weight gain
- body mass index
- stress induced
- ischemia reperfusion injury
- weight loss
- heat shock